biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0bd-01a-11w-a050-09
biospecimen_aliquot__bcr_aliquot_uuid	eba2178f-6235-49c1-a49e-98de8ffdc6a0
biospecimen_aliquot__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100470824
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-08-09
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	7
biospecimen_aliquot__plate_id	a050
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0bd-01a-11w
biospecimen_analyte__bcr_analyte_uuid	969aefb7-b86f-48a4-8496-2552128f91d6
biospecimen_analyte__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0bd
biospecimen_diagnostic_slides__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	cd4a6fc2-ba8c-4e30-972a-e6cd1bead8ad
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0bd
biospecimen_normal_control__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_portion__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0bd-01a-11
biospecimen_portion__bcr_portion_uuid	2e433e68-449a-422b-a581-e53749561611
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_portion__date_of_creation	2010-06-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	20.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0bd-01a-11w
biospecimen_protocol__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_sample__bcr_sample_uuid	832b8766-0e59-4ad4-b4c9-1e39b2ce4fb1
biospecimen_sample__days_to_collection	364
biospecimen_sample__initial_weight	90
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0bd.ce70dd1e-bca4-4f89-aa5b-d90fe18a36ff.pdf
biospecimen_sample__pathology_report_uuid	ce70dd1e-bca4-4f89-aa5b-d90fe18a36ff
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0bd-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0bd-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	b92fbb4e-3f22-48d5-9b1e-af972a45232e
biospecimen_slide__image_file_name	tcga-bh-a0bd-01a-01-tsa.b92fbb4e-3f22-48d5-9b1e-af972a45232e.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	5
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	12
biospecimen_slide__percent_stromal_cells	12
biospecimen_slide__percent_tumor_cells	75
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0bd
biospecimen_tumor_sample__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_drug__bcr_drug_barcode	tcga-bh-a0bd-d15425
clinical_drug__bcr_drug_uuid	a100360c-297c-429f-b00f-42ac189e7e5b
clinical_drug__bcr_patient_barcode	tcga-bh-a0bd
clinical_drug__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_drug__form_completion_date	2010-11-4
clinical_drug__pharma_adjuvant_cycles_count	6
clinical_drug__pharmaceutical_therapy_drug_name	doxorubicin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	166
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	61
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	86
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	522
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0bd-f15423
clinical_follow_up__bcr_followup_uuid	e292a040-7f71-48f6-83e4-1d0bf934ef28
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0bd
clinical_follow_up__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2010-11-4
clinical_follow_up__last_contact_days_to	554
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0bd
clinical_nte__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_patient__age_at_diagnosis	47
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant|left upper outer quadrant|left
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-bh-a0bd
clinical_patient__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_patient__birth_days_to	-17275
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	h-score-190
clinical_patient__er_positivity_scale_other	h-score
clinical_patient__er_status_by_ihc	positive
clinical_patient__first_surgical_procedure_other	segmental mastectomy
clinical_patient__form_completion_date	2010-11-4
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	554
clinical_patient__lymph_nodes_examined_count	9
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0bd
clinical_patient__pr_positivity_define_method	h-score-230
clinical_patient__pr_positivity_scale_other	h-score
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0bd
clinical_radiation__bcr_patient_uuid	b379bfb8-284e-4300-8325-85cfd6809cb8
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0bd-r15427
clinical_radiation__bcr_radiation_uuid	bd660dd1-5058-42e5-a3e2-c3b039b665b4
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-11-4
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	247
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	196
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0BD-01A-11W-A050-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0BD-01A-11W-A050-09.bed.meta
manually_curated__id	tcga-bh-a0bd-01a-11w-a050-09
manually_curated__md5sum	9a809f10437bc2cab75a2dcc8972834d
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	eba2178f-6235-49c1-a49e-98de8ffdc6a0
manually_curated__tumor_tag	brca
